Navigation Links
Omega-3 Fatty Acids Won't Prevent Crohn's Relapse
Date:4/8/2008

Despite earlier promise from small trial, new study finds no effect

TUESDAY, April 8 (HealthDay News) -- Omega-3 free fatty acids don't help prevent relapses in patients with Crohn's disease, concluded two studies published in the April 9 issue of the Journal of the American Medical Association.

"These studies are quite definitive," said study lead author Dr. Brian Feagan, professor of medicine and director of Robarts Clinical Trials at the Robarts Research Institute, University of Western Ontario in London, Ontario, Canada. "The bottom line is, if you're looking to prevent a relapse of Crohn's disease, these are not effective and there are other drugs that work."

Other experts, however, wondered if the dosing used in the study had anything to do with it.

"Maybe there's a perfect dose and maybe this one was too high," said Dr. Timothy Pfanner, assistant professor of internal medicine at Texas A&M Health Science Center College of Medicine and a gastroenterologist with Scott & White. "There are a bunch of medications we use now in Crohn's disease that when you start going high, there's either no benefit or a diminishment of response."

Crohn's disease involves an inflammation of the gastrointestinal tract that most often affects the lower part of the small intestine. Swelling leads to pain and diarrhea. The disease can go into periodic remission but relapses can occur.

Although there are drugs available to help prevent relapse, there is still a need for safe and effective medications. "The drugs we use now, the toxicity can be pretty high," Pfanner said. "You add one more thing on and someone can get critically ill and it's not from the Crohn's disease."

Omega-3 free fatty acids are anti-inflammatory substances found in oily cold-water fish such as salmon, mackerel, herring and sardines. They are used to treat inflammatory disorders such as rheumatoid arthritis.

One small study, involving only 78 patients, was published previously in the New England Journal of Medicine and found a 33 percent reduction in the risk of relapse in Crohn's patients taking omega-3 free fatty acids daily. Another trial, however, found no effect.

Perhaps based on the promising results of the New England Journal trial, many people with Crohn's disease began taking omega-3 free fatty acids in the hopes of preventing a relapse.

But do the supplements really work? To test that out, Feagan and his colleagues conducted two similar trials.

For the first trial, known as EPIC-1 (Epanova Program in Crohn's Study), 363 patients in remission with Crohn's disease were randomly assigned to receive either four grams per day of omega-3 fatty acids or a placebo.

The second trial, EPIC-2, involved 375 patients who were also taking either the drugs prednisone or budesonide for their Crohn's.

Participants in the treatment arm of the trials took the supplements for up to 58 weeks.

The result: Rates of relapse (as measured by a Crohn's Disease Activity Index) scores were roughly the same in all groups, the researchers found.

There is some evidence that omega-3 free fatty acids are helpful in reducing the risk for heart disease. "It's attractive in that there's no evidence that omega-3 free fatty acids are harmful," Feagan said.

But according to the researchers, the message for Crohn's sufferers is clear: other, proven medications are a better bet for preventing relapse.

More information

There's more on Crohn's disease at the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.



SOURCES: Brian G. Feagan, M.D., professor, medicine, and director of Robarts Clinical Trials at Robarts Research Institute, University of Western Ontario, London, Ontario, Canada; Timothy Pfanner, M.D., assistant professor, internal medicine, Texas A&M Health Science Center College of Medicine, and gastroenterologist, Scott & White; April 9, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dogs and Cats Need Omega-3 Fatty Acids Just as Humans Do - Nordic Naturals Offers Premium Fish Oil to Supplement Pets Diet!
2. Omega-3 Fatty Acids Protect the Spinal Cord, Heart, Brain and Eyes
3. Infant formula must contain DHA omega-3 and AA omega-6, say international experts
4. Mayo Clinic proceedings highlights research about cardiovascular benefits of omega-3 fatty acids
5. Ongoing Tests Show Kona Kampachi(R) is Rich in Omega-3s With No Detectable Mercury
6. Nordic Naturals Professional Exclusive Division Redefines High Potency Omega-3 Supplementation With New Elite Line!
7. Omega-3s Linked to Prevention of Parkinsons Disease and More
8. Maine Natural Health Company Brings Omega-3 Benefits to Pets
9. Brain, Eye and Heart Health: Three Reasons to Eat More Omega-3s
10. Omega-3s Guard Against Type 1 Diabetes
11. Drops of Fatty Acid Curb Symptoms of Dry Eye Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Omega-3 Fatty Acids Won't Prevent Crohn's Relapse
(Date:8/18/2017)... , ... August 18, 2017 , ... ... services and financial consultations to communities throughout the greater DC region, is inaugurating ... the goal of rescuing local animals and training them to be companions for ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... and financial planning services to communities in east Texas, is launching a regional ... Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has ...
(Date:8/18/2017)... John, IN (PRWEB) , ... August 18, 2017 , ... ... to communities in northwest Indiana, is campaigning in support of Campagna Academy in a ... referred to as the “Hoosier Boys’ Town of Indiana,” Campagna Academy is a nonprofit ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... The ... communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized to ... husband. , In early June of this year, Christina and her children returned from ...
(Date:8/18/2017)... ... August 18, 2017 , ... With over ... in bioidentical hormone replacement therapy and integrative medicine, has become a frontrunner for ... aging, such as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/11/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading ... data solutions, today announced that it will release its ... host a conference call at 9:00am ET. The Company ... results and its strategy and outlook for the remainder ... Erez Raphael , Chief Executive Officer, and Zvi ...
(Date:8/7/2017)... 2017 Insightin Health, provider of data-driven ... engagement, announced the selection of Michael Wood ... effective as of February 2017. In this role, Wood ... for our clients. Wood brings with him more ... business analytics within the healthcare industry. Wood formerly ...
Breaking Medicine Technology: